References
1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.Circulation . Feb 25 2014;129(8):837-47. doi:10.1161/circulationaha.113.005119
2. Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. 2020;383(14):1305-1316. doi:10.1056/NEJMoa2019422
3. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). 2020;
4. Adan V, Crown LAJAfp. Diagnosis and treatment of sick sinus syndrome. 2003;67(8):1725-1732.
5. Keller KB, Lemberg LJAJoCC. The sick sinus syndrome. 2006;15(2):226-229.
6. Mancini GJAHJ. Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success. 1982;104:617-621.
7. Jaakkola J, Hartikainen JE, Kiviniemi T, et al. Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study. 2015;47(4):341-345.
8. Shin DG, Cho I, Mun H-S, et al. Cardiovascular events of electrical cardioversion under optimal anticoagulation in atrial fibrillation: the multicenter analysis. 2015;56(6):1552-1558.
9. John RM, Kumar SJC. Sinus node and atrial arrhythmias. 2016;133(19):1892-1900.